AAM Questions FDA’s Product Identifiers in Supply Chain Guidance

Drug Industry Daily
A A
Generic drugmakers urged the FDA to allow for more flexibility in draft guidance on product identifiers under the Drug Supply Chain Security Act (DSCSA).

To View This Article:

Login

Subscribe To Drug Industry Daily